Palivizumab

From IDWiki

Revision as of 14:39, 7 November 2019 by Aidan (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to:navigation, search

Monoclonal antibody to RSV
Targets the F subunit
Limited indications (refer to RSV for details)
Main side effect is anaphylaxis
Cost about $5000 per patient per season, which reduces hospitalizations

Retrieved from "https://idwiki.org/index.php?title=Palivizumab&oldid=2755"

Antivirals